Citation

Ehrentraut JH, Kern KD, Long SA, An AQ, Faughnan LG, Anghelescu DL. J. Pediatr. Psychol. 2014; 39(10): 1149-1160.

Affiliation

Department of Psychology, Division of Anesthesia, Department of Pediatric Medicine, and Department of Biostatistics, St. Jude Children's Research Hospital.

Copyright

(Copyright © 2014, Oxford University Press)

DOI

10.1093/jpepsy/jsu072

PMID

25225182

Abstract

OBJECTIVE:  To describe the occurrence and psychosocial correlates of aberrant opioid-associated behavior (AOB) in adolescent and young adult (AYA) hematology and oncology patients prescribed opioid therapy.  METHODS:  Structured retrospective chart reviews were conducted for AYA patients (N = 398) accepted for active treatment at a large pediatric hematology/oncology institution over a 17-month period. Opioid therapy was documented in the records of 94 out of the 398 patients. The records of those 94 patients were further reviewed to identify documented AOB and documented correlates of AOB.  RESULTS:  Of the 94 patients prescribed opioid therapy, 11.7% exhibited AOB. At least one psychosocial risk factor was identified in 90.9% of patients with AOB. Concurrent use of multiple opioids was significantly associated with AOB (p =.003).  CONCLUSIONS:  Hematology/oncology AYA patients may exhibit AOB despite a legitimate clinical indication for opioid therapy. Clinicians should consider young patients' psychosocial risk factors when using opioid therapy.

Language: en